| Items | Drug Registration information |
|---|---|
| ID | 1616 |
| No | 1616 |
| Brand Name | ALISELINISO |
| Ingredients | SELINEXOR 20 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | 32 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | IN COMBINATION WITH BPRTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY, FOR THE TREATMENT OF ADULT PATIENT WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, INCLUDING DLBCL ARISING FROM FOLLICULLAR LYMPHOMA, AFTER AT LEAST 2 LINES OF SYTEMIC THERAPY |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | BLUE TABLET |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 10 L 1223/24 |
| FDD Registration Date | 31/10/2024 |
| Expiry Date | 30/10/2029 |